| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |